Mgp Ingredients INC

Market Movers (8-K)

NASDAQ
MGP Ingredients announced its second quarter 2026 financial results, showing a decrease in consolidated sales and gross profit compared to the prior year, but with adjusted EBITDA and EPS exceeding expectations.
NASDAQ
MGP Ingredients, Inc. held its 2026 Annual Meeting of Stockholders on May 13, 2026, where directors were elected, the appointment of KPMG LLP was ratified, and executive compensation was approved on an advisory basis.
NASDAQ
MGP Ingredients reported first quarter 2026 results, with sales in line with expectations and adjusted EBITDA and EPS ahead of plans, while reaffirming full-year guidance.
NASDAQ
MGP Ingredients announced the temporary idling of distilling operations at two Kentucky facilities, effective May 1, 2026, due to market oversupply, while reaffirming its full-year 2026 financial guidance.
Delay expected
NASDAQ
MGP Ingredients reported significant losses for Q4 and full-year 2025, driven by a goodwill impairment and declining sales, while providing a cautious 2026 outlook.
Delay expected
Worse than expected
NASDAQ
MGP Ingredients announces the retirement of long-serving director Karen Seaberg and the appointment of CEO Julie Francis to its Board of Directors, alongside key bylaw amendments.

Quarterly Earnings (10-Q)

NASDAQ
MGP Ingredients' Q2 2026 results show a significant decline in sales and operating income, impacted by impairments and a customer bankruptcy, though Ingredient Solutions saw growth.
Worse than expected
NASDAQ
MGP Ingredients reported a substantial net loss for Q1 2026, driven by significant goodwill and long-lived asset impairments, alongside a notable decline in sales, particularly in the Distilling Solutions segment.
Worse than expected
NASDAQ
MGP Ingredients reported a significant drop in sales and net income for Q3 and year-to-date 2025, primarily driven by reduced demand in its Distilling Solutions segment and operational challenges in Ingredient Solutions.
Capital raise
Worse than expected
NASDAQ
MGP Ingredients, Inc. announced a significant drop in sales and profitability for the second quarter and first half of 2025, primarily driven by reduced demand in its Distilling Solutions segment and supply challenges in Ingredient Solutions.
Delay expected
Worse than expected
Capital raise
NASDAQ
MGP Ingredients' Q1 2025 results reveal a significant decrease in sales and operating income compared to the previous year, driven by challenges across its Branded Spirits, Distilling Solutions, and Ingredient Solutions segments.
Worse than expected
NASDAQ
MGP Ingredients experienced a decrease in sales across all segments in the third quarter, while also seeing improved gross margins in Branded Spirits and a significant increase in operating income due to non-recurring items.
Worse than expected

Annual Reports (10-K)

NASDAQ
MGP Ingredients reported a significant net loss of $107.8 million for 2025, driven by substantial goodwill and intangible asset impairments in its Branded Spirits segment and broad revenue declines across all business units.
Worse than expected
NASDAQ
MGP Ingredients experienced a decrease in sales and operating income for the year ended December 31, 2024, primarily due to softening American whiskey category trends and a goodwill impairment charge.
Worse than expected
NASDAQ
MGP Ingredients, Inc. reports a 7% increase in sales for fiscal year 2023, driven by growth across all segments, while also managing strategic changes including the closure of the Atchison distillery.
Worse than expected

Insider Trading (Form 4)

NASDAQ
MGP Ingredients Director Martin Roper acquired 2,232 shares of common stock valued at $17.36 per share as a non-cash retainer for his services.
NASDAQ
Reporting person Caroline Lux Kaplan sold 60,000 shares of MGP Ingredients Inc. common stock via a trust over two days.
NASDAQ
Director Lori Mingus was granted 5,801 shares of MGP Ingredients common stock as part of her annual director compensation.
NASDAQ
Director Jennifer Lowry acquired 5,801 shares of MGP Ingredients, Inc. common stock as part of an annual director compensation award.
NASDAQ
Director Todd B. Siwak acquired 5,801 shares of MGP Ingredients common stock as part of an annual director compensation award.
NASDAQ
Director Gerardo I. Lopez was granted 5,801 shares of MGP Ingredients common stock as part of an annual director compensation award.

Proxy Statements (Def-14A)

NASDAQ
MGP Ingredients announces Jennifer Lowry as an additional nominee for Group B director to be voted on by preferred stockholders at the upcoming 2025 Annual Meeting.
NASDAQ
MGP Ingredients invites stockholders to its 2025 Annual Meeting on May 20, 2025, to elect directors, ratify the accounting firm, and approve executive compensation.
Worse than expected
NASDAQ
MGP Ingredients, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NASDAQ
MGP Ingredients is asking stockholders to approve a new equity incentive plan to replace the existing plans that expired on April 1, 2024, aiming to align executive and director compensation with company performance and stockholder interests.

Schedule 13D - Activist Investments

NASDAQ
The Lux family and associated trusts updated their Schedule 13D filing for MGP Ingredients, Inc., detailing beneficial ownership of 31.4% of common stock, including a group with Seaberg/Cray Shareholders.
NASDAQ
A group of beneficial owners, including Karen Seaberg, has significantly reduced its holdings in MGP Ingredients, Inc. through open market sales and redemptions.
Worse than expected
NASDAQ
An amendment to Schedule 13D reveals updated beneficial ownership percentages and recent share sales by the Lux family group in MGP Ingredients Inc.
NASDAQ
Karen Seaberg and related entities updated their beneficial ownership in MGP Ingredients, disclosing a delay in a significant share redemption agreement until September 2026.
Delay expected
NASDAQ
An amendment to Schedule 13D reveals that the Lux family and associated trusts, along along with the Seaberg/Cray Shareholders, collectively maintain a 33.9% beneficial ownership in MGP Ingredients Inc., despite recent share sales by some group members.
NASDAQ
Karen Seaberg and affiliated entities have filed an amended Schedule 13D, revealing updated beneficial ownership of MGP Ingredients Inc. common stock and detailing recent open market share sales.
Worse than expected

Schedule 13G - Passive Investments

NASDAQ
Federated Hermes, Inc. and associated entities report a beneficial ownership stake of 4.59% in MGP Ingredients, Inc. as of June 30, 2026.
NASDAQ
Federated Hermes, Inc. and associated entities have disclosed a passive ownership stake of 5.59% in MGP Ingredients Inc, representing over 1.19 million shares.
NASDAQ
The Vanguard Group has amended its Schedule 13G for MGP Ingredients Inc., reporting 0% beneficial ownership following an internal realignment.
NASDAQ
BlackRock, Inc. has increased its beneficial ownership in MGP Ingredients Inc. to 5.01% of the common stock, holding 1,067,363 shares as of December 31, 2025.
NASDAQ
Federated Hermes, Inc. and related entities have filed an amended Schedule 13G, disclosing beneficial ownership of 6.75% of MGP Ingredients, Inc. common stock as of December 31, 2025.
NASDAQ
Federated Hermes, Inc. and related entities have reported a 5.17% beneficial ownership stake in MGP Ingredients Inc. common stock, held for investment purposes.